Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer

Fig. 4

β2-AR overexpression correlates with DFS and LNM in breast cancer patients. a and b, The rates of DFS (a) and OS (b) in the patients with Her2-positive metastatic breast cancer according to the expression level of β2-AR were determined by the Kaplan-Meier analysis. c, The expression of Her2 and β2-AR was analyzed using a tissue microarray containing 50 metastatic lymph nodes from breast cancer patients by immunohistochemical staining. The middle and right panels are the magnifications of the square regions in the left and middle panels, respectively. Bar = 1000 μm (low-power field), 200 μm or 100 μm (high-power field). d, The relationship between LNM and β2-AR expression was evaluated in Her2-overexpressing breast cancer

Back to article page